Drugs Flashcards

Know the Drugs, analogs and functions.

You may prefer our related Brainscape-certified flashcards:
1
Q

Zidovudine

Azidothymidine, AZT

A

Anti-viral Nucleoside analogues – Viral reverse transcriptase inhibitors

Deoxythymidine analogue

Utilized by the viral reverse transcriptase
Upon incorporation into the double stranded DNA chain termination occurs due to lack of 3’OH
Zidovudine can:-
• Prolong life in HIV infected individuals
• Reduce mother to baby transmission by more than 20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Didanosine (ddI)

A

Anti-viral Nucleoside analogues – Viral reverse transcriptase inhibitors

Deoxyadenosine analogue

Utilised by the viral reverse transcriptase
Upon incorporation into the double stranded DNA, chain termination occurs due to lack of 3’OH.

Specificity for infected cells lies in the fact that these drugs have a 100-300 fold greater affinity for incorporation by reverse transcriptase than eukaryotic DNA polymerase.

Used in the treatment of mainly HIV in combination with other anti-virals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Acyclovir

A

Anti-viral Nucleoside analogues – Viral DNA polymerase inhibitor

Deoxy(guanosine) analogue

Converted to the mono-phosphate by viral thymidine kinase which is much more effective in catalyzing 1st phosphorylation event than host thymidine kinase

Only infected cells possess the viral kinase
Therefore Acyclovir is only activated in infected cells.

It serves as as substrate for viral DNA polymerase.
It causes chain termination due to lack of 3’OH.
It’s 30 x more potent against viral DNA polymerase than host.
Viral kinase

High specificity for herpes simplex & varicella zoster.
Herpes simplex can causes conjunctivitis and coldsores

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Tenofovir

A

Anti-viral Nucleotide Base analogues

Deoxyadenosine monophosphate analog

Tenofovir diphosphate competes with its natural nucleotide counterpart, deoxyadenosine 5 ́-triphosphate, for incorporation into newly forming HIV DNA.
Once successfully incorporated, termination of the elongating DNA chain ensues, and DNA synthesis is interrupted.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cytosine Arabinoside

Cytarabine or araC

A

Cytosine nucleoside analogue

Ribose sugar replaced by arabinose

In cells it is rapidly converted
to cytosine arabinoside triphosphate which
acts as a substrate for several human DNA Polymerization.

AraC has a 3’ OH group to act as an acceptor for further chain elongation. However the OH gp at posn., 2 prevents polymerase adding the next dNTP due to stereo restraints causing chain termination.
Important in the therapy of leukaemias, in particular acute myeloid Leukaemia and Lymphoma (Anti cancer agent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Adenosine Arabinoside

Vidarabine or araA

A

Deoxyadenosine analogue

3’OH is present but planar configuration of the arabinoside prevents DNA elongation

Uses:
Anti-neoplastic agent - Relapsed Childhood Acute Lymphoblastic Leukemia Herpes Simplex infections (Anti cancer agent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Decitabine
(5-aza-2’-deoxycytidine)

         and 

5-azacytidine

A

Cytidine Analogues – DNA hypomethylation Agents

Deoxycytidine analogues

Once incorporated into DNA and RNA they cause hypomethylation as a methyl group cannot be added to the Nitrogen at position 5.

Additionally, these drugs are know to bind and inhibit DNA methyltransferase enzymes.
Prevents DNA methylation

In eukaryotes, methylation of cytosine is an important mechanism of transcriptional regulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

An example of the use of DNA hypomethylating agents in Cancer….(Decitabine)

A

P15 Tumour suppressor gene –p15INK4b

Decitabine causes Hypomethylation

CDKN2B in a HYPOMETHYLATED promoter regions causes TRANSCRIPTION and p15INK4b prevents malignant transformation (inhibits cyclin dependent kinases)

CDKN2B in a HYPERMETHYLATED promoter regions causes TRANSCRIPTIONAL SILENCING therefore No p15INK4b transcribed= Uncontrolled cell division allowing tumor formation

Hypomethylation of CDKN2B correlates with response to decitabine
Used in Myelodysplastic syndrome & Acute myeloid leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ciprofloxacin

A

inhibits bacterial DNA gyrase (topoisomerase II)

quinolone drug

It is used in the treatment of respiratory and urinary tract infections and can be used to treat anthrax.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Camptothecin

A

Inhibitors of eukaryote replication

an anticancer drug
binds to and inhibits topoisomerase I activity whch result is DNA breakage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Etoposide

A

another anticancer drug

inhibits the activity of topisomerase II (DNA Gyrase).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Actinomycin D

Dactinomycin

A

Inhibitors of replication

Drug- DNA complex….stable

Prevents DNA replication by:

  • binds tightly to double stranded DNA preventing the formation of regions of single stranded DNA.
  • Inhibits RNA transcription and replication in both prokaryotes and eukaryotes (as it prevents strand separation)
  • primarily used as an anti-cancer drug (inhibiting DNA replication and cell division)
  • not normally used as an antibiotic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Rifampin

A
  • an antibiotic from a strain of Streptomyces
  • inhibits initiation of transcription
  • blocks formation of the first phospho- diester bond by binding to prokaryote RNA polymerase and changing its conformation
  • RNA polymerase of eukaryotes is not affected
  • used in the treatment of tuberculosis

Mutations in the genes encoding the target proteins such as RNA polymerase and topoisomerases can lead to drug resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Alpha-Amanitin

toxin from Amanita phalloides/The Death Cap Mushroom

A

potent inhibitor of RNA polymerase II….which prevents mRNA transcription

There are four clinical phases of poisoning:
1) Asymptomatic phase
2) Gastrointestinal phase (1-2 days) - severe diarrhea
and vomiting
3) Apparent recovery phase - few symptoms
4) Hepatic phase - renal and liver failure
*** death may occur in 7-10 days

Treatment:

  • gastrointestinal decontamination
  • high dose penicillin (inhibits amanitin activity in liver)
  • liver transplant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Courmarins

including Novobiocin

A

Inhibits bacterial gyrase (topoisomerases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Quinolones

including Nalidixic Acid and Ciprofloxacin

A

Inhibits bacterial gyrase (topoisomerases)

17
Q

Systemic Lupus Erythematosis

A

Lupus is an autoimmune disease with multiple symptoms including extreme fatigue, arthritis, fever skin rashes and kidney problems.

Individuals with this condition possess antibodies that react with the U1 RNA component of the spliceosome.

This will prevent normal splicing of mRNAs.

18
Q

alternative splicing

A

Allows a number of different proteins to be produced from the same gene

eg:
Tissue-specific isoforms 
Membrane bound or soluble isoforms
Alternative intracellular localization 
Altered function
19
Q

Beta-thalassemia

A

Mutations in genes that affect the sequence of splice donor/acceptor sites or that create new splice donor/acceptor sites can cause clinical effects:

For example, beta-thalassemia

Many individuals with beta-thalassemia have mutations in the beta- globin gene that generate additional splice sites within the mRNA.
As a result, frame shifts or premature stop codons are introduced into the mature mRNA.
This results in the production of an abnormal beta-globin protein.

20
Q

Limb Girdle Muscular Dystrophy

A

a mutation in the calpain-3 gene that generates a new splice site within the exon 16 (coding sequence).
This results in a shorter calpain-3 mRNA that is missing exon 16 codons. This produces a defective protein.

21
Q

RNA editing

A

RNA editing is a process in which information changes at the level of mRNA.

It is revealed by situations in which the coding sequence in an RNA differs from the sequence of DNA from which it was transcribed.

In mammalian cells there are cases in which a substitution occurs in an individual base in mRNA, causing a change in the sequence of the protein that is coded.

In trypanosome mitochondria, more widespread changes occur in transcripts when bases are added or deleted.

22
Q

cytidine deaminase enzyme.

A

In mammals, the apo-B gene encodes two alternative forms of the apolipoprotein B: Apo-B100 (liver) and Apo-B48 (intestine).
In the intestine, the apo-B mRNA is edited so that a premature stop codon is produced (CAA

23
Q

adenosine deaminase enzyme.

A

Glutamate receptor in the brain
Editing of the glutamate receptor involves a single base change from A to I (inosine). This editing results in a codon change within the mRNA from glutamine to arginine.
The editing affects an amino acid located in the inner wall of the ion channel and alters Ca2+ permeability. This editing is a requirement for proper brain development. This editing is accomplished by the enzyme adenosine deaminase.

24
Q

Diphtheria toxin

A

inactivates EF-2 (elongation factor in eukaryotes)

Diphtheria bacteria become pathogenic when the bacterium itself is infected with a lysogenic phage (bacterial virus)

Diphtheria toxin enzymatically destroys E2-F which blocks translation elongation
A single molecule of diphtheria toxin may destroy all of the EF-2 proteins in the cell

Immunization protects against it

25
Q

Streptomycin

A

Antibiotics - affect protein synthesis
Inhibition of Initiation

•An aminoglycoside
•Binds to 30s ribosomal subunit •Distorts structure •Prevents assembly of complete ribosome
Prevents initiation

26
Q

Tetracycline

other family members

  • Monocycline
  • Doxorubicin
  • Doxycycline
  • etc…
A

Antibiotics - affect protein synthesis
Inhibitor of Elongation

  • Tetracyclin blocks elongation
  • 4 rings (tetra) structure
  • Interacts with the 30S subunit of the complete (70s) ribosome
  • Prevent the incoming aminoacyl-tRNA to access the A-site
27
Q

Erythromycin

A

Antibiotics - affect protein synthesis
Inhibitor of Elongation

  • Macrolide structure
  • Binds to 50S subunit of the complete (70s) ribosome
  • Blocks elongation by preventing ribosome movement relative to mRNA
  • Blocks ribosome translocation
28
Q

Chloramphenicol

A

Antibiotics - affect protein synthesis
Inhibitor of Elongation

•Inhibits prokaryotic peptidyl transferase activity (elongation)
•Not used widely in developed countries
•May inhibit mitochondrial ribosomes(translation)
• Important in some cases (i.e. some meningitis conditions)

29
Q

Cycloheximide

A

Antibiotics - affect protein synthesis
Inhibitor of Elongation

Its a simple (relatively cheap) organic molecule that inhibits peptidyl-transferasre (elongation) in eukaryotes
-Similar mechanism to chloramphenicol
•Extremely toxic to eukaryotes (prokaryotes and mitochondria not affected)
•Widely used in laboratories (extremely cheap)

30
Q

Puromycin

A

Antibiotics - affect protein synthesis
Inhibitor of Elongation

structural analog to a portion of the aminoacyl-tRNA

  • Puromycin is toxic to both eukaryotes and prokaryotes - not clinically useful
  • Puromycin blocks elongation – Peptide may form to –NH3 group, but, is then stuck
  • Puromycin causes the peptide to fall out of the ribosome P-site, and causes premature translation termination
31
Q

Prozac

Fluoxetine

A
  • antidepressant drug that blocks serotonin elimination from synaptic cleft.
    •Serotonin re-uptake inhibitor
    • Enhances the action of the neurotransmitter.
32
Q

Lysergic acid diethylamide (LSD)

Lucy in the sky with diamond

A

-affects serotonin receptors that are located in the brain stem.

33
Q

Allopurinol

A

-used for treatment of gout in patients who are “overproducer” of uric acid.

Allopurinol inhibition of xanthine oxidase
can be described as suicide inhibition
as the drug itself is used as substrate for xanthine oxidase and then modified to an irreversible inhibitor.
The newly formed alloxanthine (oxypurinol) interferes with the cofactor molybdenum that is needed for xanthine oxidase itself.